Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (3y) (2013 - 2026)
Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.37% |
| Mar 31, 2026 | 50.77% |
| Dec 31, 2025 | 30.44% |
| Sep 30, 2025 | 21.37% |
| Jun 30, 2025 | 70.96% |
| Mar 31, 2025 | 16.20% |
| Nov 30, 2021 | -17.84% |
| Aug 31, 2021 | -149.13% |
| May 31, 2021 | -104.94% |
| Feb 28, 2021 | -93.03% |
| Nov 30, 2020 | -81.40% |
| Aug 31, 2020 | -61.64% |
| May 31, 2020 | -54.29% |
| Feb 29, 2020 | -14.00% |
| Nov 30, 2019 | 49.14% |
| Aug 31, 2019 | -1.30% |
| May 31, 2019 | -2.33% |
| Feb 28, 2019 | -63.42% |
| Nov 30, 2018 | -22.06% |
| Aug 31, 2018 | 27.95% |